Semiconductors
Compare Stocks
5 / 10Stock Comparison
ALAB vs MTSI vs MRVL vs LITE vs AVGO
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Communication Equipment
Semiconductors
ALAB vs MTSI vs MRVL vs LITE vs AVGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Communication Equipment | Semiconductors |
| Market Cap | $33.30B | $25.84B | $138.57B | $63.74B | $1.96T |
| Revenue (TTM) | $1.00B | $1.07B | $8.19B | $2.49B | $68.28B |
| Net Income (TTM) | $268M | $177M | $2.67B | $440M | $24.97B |
| Gross Margin | 76.0% | 55.3% | 51.0% | 37.7% | 67.1% |
| Operating Margin | 22.4% | 16.0% | 16.1% | 9.5% | 40.9% |
| Forward P/E | 67.6x | 73.3x | 44.3x | 110.1x | 36.5x |
| Total Debt | $35M | $538M | $4.47B | $2.61B | $65.14B |
| Cash & Equiv. | $168M | $112M | $2.64B | $521M | $16.18B |
ALAB vs MTSI vs MRVL vs LITE vs AVGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 24 | May 26 | Return |
|---|---|---|---|
| Astera Labs, Inc. C… (ALAB) | 100 | 269.3 | +169.3% |
| MACOM Technology So… (MTSI) | 100 | 376.3 | +276.3% |
| Marvell Technology,… (MRVL) | 100 | 240.0 | +140.0% |
| Lumentum Holdings I… (LITE) | 100 | 1908.0 | +1808.0% |
| Broadcom Inc. (AVGO) | 100 | 324.4 | +224.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALAB vs MTSI vs MRVL vs LITE vs AVGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALAB is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 115.1%, EPS growth 290.6%, 3Y rev CAGR 120.2%
- 115.1% revenue growth vs LITE's 21.0%
- 18.3% ROA vs LITE's 8.5%, ROIC 12.3% vs -4.3%
MTSI ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.75, Low D/E 40.5%, current ratio 3.71x
- Beta 1.75 vs ALAB's 2.99
Among these 5 stocks, MRVL doesn't own a clear edge in any measured category.
LITE is the clearest fit if your priority is long-term compounding.
- 36.4% 10Y total return vs AVGO's 29.0%
- +12.5% vs AVGO's +102.6%
AVGO carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 16 yrs, beta 1.96, yield 0.6%
- Beta 1.96, yield 0.6%, current ratio 1.71x
- Lower P/E (36.5x vs 110.1x)
- 36.6% margin vs MTSI's 16.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 115.1% revenue growth vs LITE's 21.0% | |
| Value | Lower P/E (36.5x vs 110.1x) | |
| Quality / Margins | 36.6% margin vs MTSI's 16.5% | |
| Stability / Safety | Beta 1.75 vs ALAB's 2.99 | |
| Dividends | 0.6% yield, 16-year raise streak, vs MRVL's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +12.5% vs AVGO's +102.6% | |
| Efficiency (ROA) | 18.3% ROA vs LITE's 8.5%, ROIC 12.3% vs -4.3% |
ALAB vs MTSI vs MRVL vs LITE vs AVGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ALAB vs MTSI vs MRVL vs LITE vs AVGO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVGO leads in 3 of 6 categories
LITE leads 1 • MTSI leads 1 • ALAB leads 0 • MRVL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVGO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVGO is the larger business by revenue, generating $68.3B annually — 68.2x ALAB's $1.0B. AVGO is the more profitable business, keeping 36.6% of every revenue dollar as net income compared to MTSI's 16.5%. On growth, ALAB holds the edge at +93.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $1.1B | $8.2B | $2.5B | $68.3B |
| EBITDAEarnings before interest/tax | $233M | $210M | $2.3B | $425M | $38.8B |
| Net IncomeAfter-tax profit | $268M | $177M | $2.7B | $440M | $25.0B |
| Free Cash FlowCash after capex | $343M | $168M | $1.4B | $399M | $28.9B |
| Gross MarginGross profit ÷ Revenue | +76.0% | +55.3% | +51.0% | +37.7% | +67.1% |
| Operating MarginEBIT ÷ Revenue | +22.4% | +16.0% | +16.1% | +9.5% | +40.9% |
| Net MarginNet income ÷ Revenue | +26.7% | +16.5% | +32.6% | +17.7% | +36.6% |
| FCF MarginFCF ÷ Revenue | +34.2% | +15.6% | +17.0% | +16.0% | +42.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.4% | +22.5% | +22.1% | +90.1% | +29.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +144.4% | +42.9% | +100.0% | +3.3% | +31.6% |
Valuation Metrics
AVGO leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 52.1x trailing earnings, MRVL trades at a 98% valuation discount to LITE's 2412.9x P/E. On an enterprise value basis, AVGO's 58.5x EV/EBITDA is more attractive than LITE's 859.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $33.3B | $25.8B | $138.6B | $63.7B | $1.96T |
| Enterprise ValueMkt cap + debt − cash | $33.2B | $26.3B | $140.4B | $65.8B | $2.00T |
| Trailing P/EPrice ÷ TTM EPS | 160.37x | -471.88x | 52.12x | 2412.94x | 86.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 67.61x | 73.25x | 44.32x | 110.06x | 36.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.73x |
| EV / EBITDAEnterprise value multiple | 184.02x | 136.13x | 106.14x | 859.43x | 58.52x |
| Price / SalesMarket cap ÷ Revenue | 39.06x | 26.71x | 16.91x | 38.75x | 30.62x |
| Price / BookPrice ÷ Book value/share | 25.76x | 19.20x | 9.73x | 54.76x | 24.63x |
| Price / FCFMarket cap ÷ FCF | 118.19x | 134.01x | 99.24x | — | 72.67x |
Profitability & Efficiency
Evenly matched — ALAB and AVGO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
AVGO delivers a 32.9% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $13 for MTSI. ALAB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to LITE's 2.30x. On the Piotroski fundamental quality scale (0–9), AVGO scores 8/9 vs MTSI's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.3% | +13.2% | +19.4% | +30.7% | +32.9% |
| ROA (TTM)Return on assets | +18.3% | +8.6% | +12.6% | +8.5% | +14.9% |
| ROICReturn on invested capital | +12.3% | +6.0% | +6.0% | -4.3% | +14.9% |
| ROCEReturn on capital employed | +14.7% | +7.6% | +7.1% | -4.8% | +16.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.03x | 0.41x | 0.31x | 2.30x | 0.80x |
| Net DebtTotal debt minus cash | -$132M | $426M | $1.8B | $2.1B | $49.0B |
| Cash & Equiv.Liquid assets | $168M | $112M | $2.6B | $521M | $16.2B |
| Total DebtShort + long-term debt | $35M | $538M | $4.5B | $2.6B | $65.1B |
| Interest CoverageEBIT ÷ Interest expense | — | 391.47x | 15.17x | 9.62x | 9.24x |
Total Returns (Dividends Reinvested)
LITE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LITE five years ago would be worth $107,656 today (with dividends reinvested), compared to $31,541 for ALAB. Over the past 12 months, LITE leads with a +1247.8% total return vs AVGO's +102.6%. The 3-year compound annual growth rate (CAGR) favors LITE at 165.2% vs ALAB's 46.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.0% | +96.9% | +79.1% | +131.2% | +18.9% |
| 1-Year ReturnPast 12 months | +175.2% | +203.8% | +184.6% | +1247.8% | +102.6% |
| 3-Year ReturnCumulative with dividends | +215.4% | +526.9% | +291.9% | +1764.2% | +566.4% |
| 5-Year ReturnCumulative with dividends | +215.4% | +513.6% | +250.8% | +976.6% | +833.6% |
| 10-Year ReturnCumulative with dividends | +215.4% | +795.9% | +1581.3% | +3635.5% | +2897.3% |
| CAGR (3Y)Annualised 3-year return | +46.7% | +84.4% | +57.7% | +165.2% | +88.2% |
Risk & Volatility
MTSI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MTSI is the less volatile stock with a 1.75 beta — it tends to amplify market swings less than ALAB's 2.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MTSI currently trades 97.0% from its 52-week high vs ALAB's 74.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.03x | 1.69x | 2.27x | 2.66x | 1.96x |
| 52-Week HighHighest price in past year | $262.90 | $355.00 | $175.79 | $1021.00 | $437.68 |
| 52-Week LowLowest price in past year | $63.40 | $110.09 | $53.78 | $60.38 | $198.43 |
| % of 52W HighCurrent price vs 52-week peak | +74.4% | +97.0% | +91.0% | +87.4% | +94.3% |
| RSI (14)Momentum oscillator 0–100 | 69.8 | 71.3 | 78.5 | 58.8 | 68.0 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 1.1M | 24.8M | 6.4M | 23.3M |
Analyst Outlook
AVGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALAB as "Buy", MTSI as "Buy", MRVL as "Buy", LITE as "Buy", AVGO as "Buy". Consensus price targets imply 17.7% upside for ALAB (target: $230) vs -16.8% for MRVL (target: $133). For income investors, AVGO offers the higher dividend yield at 0.56% vs MRVL's 0.15%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $230.27 | $332.00 | $133.10 | $918.67 | $443.72 |
| # AnalystsCovering analysts | 16 | 23 | 72 | 25 | 58 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.1% | — | +0.6% |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 0 | 16 |
| Dividend / ShareAnnual DPS | — | — | $0.24 | — | $2.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +1.5% | +0.1% | +0.3% |
AVGO leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). LITE leads in 1 (Total Returns). 1 tied.
ALAB vs MTSI vs MRVL vs LITE vs AVGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALAB or MTSI or MRVL or LITE or AVGO a better buy right now?
For growth investors, Astera Labs, Inc.
Common Stock (ALAB) is the stronger pick with 115. 1% revenue growth year-over-year, versus 21. 0% for Lumentum Holdings Inc. (LITE). Marvell Technology, Inc. (MRVL) offers the better valuation at 52. 1x trailing P/E (44. 3x forward), making it the more compelling value choice. Analysts rate Astera Labs, Inc. Common Stock (ALAB) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALAB or MTSI or MRVL or LITE or AVGO?
On trailing P/E, Marvell Technology, Inc.
(MRVL) is the cheapest at 52. 1x versus Lumentum Holdings Inc. at 2412. 9x. On forward P/E, Broadcom Inc. is actually cheaper at 36. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ALAB or MTSI or MRVL or LITE or AVGO?
Over the past 5 years, Lumentum Holdings Inc.
(LITE) delivered a total return of +976. 6%, compared to +215. 4% for Astera Labs, Inc. Common Stock (ALAB). Over 10 years, the gap is even starker: LITE returned +36. 8% versus ALAB's +222. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALAB or MTSI or MRVL or LITE or AVGO?
By beta (market sensitivity over 5 years), MACOM Technology Solutions Holdings, Inc.
(MTSI) is the lower-risk stock at 1. 69β versus Astera Labs, Inc. Common Stock's 3. 03β — meaning ALAB is approximately 80% more volatile than MTSI relative to the S&P 500. On balance sheet safety, Astera Labs, Inc. Common Stock (ALAB) carries a lower debt/equity ratio of 3% versus 2% for Lumentum Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALAB or MTSI or MRVL or LITE or AVGO?
By revenue growth (latest reported year), Astera Labs, Inc.
Common Stock (ALAB) is pulling ahead at 115. 1% versus 21. 0% for Lumentum Holdings Inc. (LITE). On earnings-per-share growth, the picture is similar: Marvell Technology, Inc. grew EPS 401. 0% year-over-year, compared to -170. 2% for MACOM Technology Solutions Holdings, Inc.. Over a 3-year CAGR, ALAB leads at 120. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALAB or MTSI or MRVL or LITE or AVGO?
Broadcom Inc.
(AVGO) is the more profitable company, earning 36. 2% net margin versus -5. 6% for MACOM Technology Solutions Holdings, Inc. — meaning it keeps 36. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVGO leads at 39. 9% versus -10. 9% for LITE. At the gross margin level — before operating expenses — ALAB leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALAB or MTSI or MRVL or LITE or AVGO more undervalued right now?
On forward earnings alone, Broadcom Inc.
(AVGO) trades at 36. 5x forward P/E versus 110. 1x for Lumentum Holdings Inc. — 73. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALAB: 17. 7% to $230. 27.
08Which pays a better dividend — ALAB or MTSI or MRVL or LITE or AVGO?
In this comparison, AVGO (0.
6% yield), MRVL (0. 1% yield) pay a dividend. ALAB, MTSI, LITE do not pay a meaningful dividend and should not be held primarily for income.
09Is ALAB or MTSI or MRVL or LITE or AVGO better for a retirement portfolio?
For long-horizon retirement investors, Marvell Technology, Inc.
(MRVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1686% 10Y return). Lumentum Holdings Inc. (LITE) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MRVL: +1686%, LITE: +36. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALAB and MTSI and MRVL and LITE and AVGO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
AVGO pays a dividend while ALAB, MTSI, MRVL, LITE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.